版本:
中国

BRIEF-Revance Therapeutics says entered into services agreement with Ajinomoto Althea

March 15 Revance Therapeutics Inc

* Revance therapeutics inc- on march 14, 2017 co entered into services agreement with ajinomoto althea, inc.- sec filing

* Revance therapeutics-under agreement,althea has agreed to provide co with future source of commercial fill/finish services for neuromodulator products

* Revance therapeutics inc- services agreement has an initial term that will expire in seven years

* Revance therapeutics- agreement provides co expanded capacity,second source of drug product manufacturing to support launch of daxibotulinumtoxina for injection (rt002) Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐